newsfilter
← Latest News
GlobeNewswire·

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

BRIDGEWATER, N.J., April 09, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the launch of bimatoprost ophthalmic solution 0.01% (2.5 mL, 5 mL and 7.5 mL). The product